Insilico’s AI-driven IPF candidate rentosertib shows potential for biological age reversal, as assessed by six proteomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results